Regorafenib CAS No.755037-03-7
1 Inquiries
755037-03-7
Pharmaceutical grade
99%
Shanghai
JINLAN PHARM
25Kg/drum
2022-12-31
additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Regorafenib
Other Name:2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-;4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide;4-[4-[N′-(4-Chloro-3-trifluoromethylphenyl)ureido]-3-fluorophenoxy]pyridine-2-carboxylic acid methylamide;Regorafenib;BAY 73-4506;Stivarga;1219951-07-1;1370461-45-2
CAS No.:755037-03-7
Molecular Formula:C21H15ClF4N4O3
InChIKeys:InChIKey=FNHKPVJBJVTLMP-UHFFFAOYSA-N
Molecular Weight:482.815
Exact Mass:482.82
UNII:24T2A1DOYB
DSSTox ID:DTXSID60226441
NCI Thesaurus Code:C78204
ATC Code:L01XE21|L - Antineoplastic and immunomodulating agents
HScode:29242990
Categories:
Characteristics-
PSA:
92.35000
XLogP3:4.2
Density:1.5±0.1 g/cm3
Melting Point:206.0 to 210.0 °C
Boiling Point:513.4±50.0 °C at 760 mmHg
Flash Point:264.3±30.1 °C
Refractive Index:1.616
Water Solubility:Insoluble
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 1B
Reproductive toxicity, Additional category for effects on or via lactation
Specific target organ toxicity â repeated exposure, Category 1
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H360 May damage fertility or the unborn child
H362 May cause harm to breast-fed children
H372 Causes damage to organs through prolonged or repeated exposure
H400 Very toxic to aquatic life
H410 Very toxic to aquatic life with long lasting effects
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P263 Avoid contact during pregnancy and while nursing.
P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P273 Avoid release to the environment.
Response P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
P391 Collect spillage.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst
-
Location:
hangzhou,zhejiang
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
30
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2020
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
France
Regorafenib
1 KG Feb 13, 2024 Post an enquiry for this product
